Company ProfilePremium

SI Group, Inc.

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
SI Group, Inc. - Company showcase

Year Founded & Workforce

1906

1,500 Employees

SI Group, Inc. logo

SI Group, Inc. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

SI Group, Inc. Overview

SI Group is a mid-sized, private, global maker of performance additives and chemical intermediates. Its core is antioxidant and stabilizer chemistry: phenolic, aminic and phosphite antioxidants, UV stabilizers and coupling agents. It is backward-integrated into alkylphenols and alkylated cresols. The company also has a long-established franchise in phenolic resins for tires and rubber (tackifying, reinforcing, bonding and curing resins), resins and intermediates for oilfield production chemistry, and specialty intermediates such as 4,4'-biphenol. The current company was formed in 2018 by combining legacy SI Group (Schenectady) with SK Capital's Addivant (the former Chemtura antioxidants business). Its stated vision is to become "the global performance additives powerhouse". Since 2021 it has divested non-core resins, closed high-cost Asian plants, exited ibuprofen and gone through two balance-sheet restructurings (2024 and 2025). After cutting net debt by about USD 1.7B in December 2025, it is now trying to return to growth through regional partnerships (Azelis, Dingjide, Shengxiao), new innovation centres and pricing actions.


Company's own description. SI Group describes itself as a global leader in performance additives, process solutions and chemical intermediates (2026 boilerplate). Its chemistries improve the quality and performance of industrial and consumer goods in plastics, rubber and adhesives, fuels, lubricants, coatings and oilfield. Before 2026 the boilerplate also named "pharmaceuticals" and "active pharmaceutical ingredients". That wording disappears from 2026 releases, though it remains in the website metadata. Read together, this suggests the company is de-emphasizing APIs after it ended ibuprofen production in 2024. [siigroup.com/about; PRs Dec 2025 vs Mar–Jul 2026]

Five "Key Strategic Markets" (the company's own organizing framework) [siigroup.com/about, 2026]:

  1. Core Solutions: chemical intermediates for industrial uses and other end markets.

  2. Fuel, Lubricants & Coatings: antioxidants, intermediates and specialty additives for coatings, fuels, greases and lubricants.

  3. Oilfield: resins and intermediates for oilfield production chemistry.

  4. Plastics: antioxidants, non-dust blends and additives for plastics stabilization, compounding and circularity.

  5. Rubber & Adhesives: resins and additives for tires, technical rubber goods and adhesives.

Business model. This is an almost entirely product-based model. SI Group manufactures and sells chemicals on volume contracts and spot orders, directly to large accounts and through distributors in other regions (Brenntag in EMEA since 2005; Azelis added for EMEA plastics additives from 1 January 2026). Service revenue (technical service, application development at six innovation centres) is bundled into product pricing and not monetized separately. No subscription or licensing revenue is disclosed. Two exceptions involve technology deals: in 2021 SI Group licensed industrial-resins technology to ASK Chemicals, and in 2026 it contributed proprietary biphenol technology to the Shengnova JV. Toll and co-production arrangements, such as the one with Dingjide in China, are increasingly part of the supply model. [Company PRs 2021, 2024, 2025, 2026]

Revenue model mix (estimate of character, not disclosed numerically).

Value-chain position. SI Group is a mid-stream specialty producer. It buys petrochemical building blocks (phenol, isobutylene and other olefins, cresols, phosphorus chemicals, amines). It converts them into alkylphenol intermediates, then into higher-value antioxidants and resins, which it sells to compounders, polymer producers, tire makers, lubricant and fuel additive blenders, and oilfield service and chemical formulators. The 2018 SK Capital rationale described the combined company as backward-integrated into key chemical intermediates. [SK Capital PR, 15 Oct 2018]

Customer types. Customers include polyolefin and engineering-polymer producers and compounders; tire and technical-rubber manufacturers; adhesive formulators; lubricant, grease and fuel-additive companies; oilfield chemical formulators; coatings producers; and, historically, pharmaceutical formulators (ibuprofen, propofol).

End-markets served. The website lists agriculture, automotive, building and construction, chemical intermediates, coatings, consumer goods, elastomers, electronics, fuel additives, furniture, grease additives, health and nutrition, lubricant additives, metal processing, oil and gas, oilfield chemicals, packaging, personal care, recycling, textiles, and tire and rubber. [siigroup.com navigation, 2026]

Independent characterization. SI Group is a sub-scale but well-franchised antioxidant and stabilizer house. Its competitors are far larger (BASF, Songwon, Adeka) or low-cost Chinese producers (e.g., Rianlon). Its differentiation rests on four things: (i) integration into alkylphenols, where it claims market leadership; (ii) legacy brands from Addivant/Chemtura (NAUGARD, ANOX, LOWINOX, WESTON) and Albemarle (ETHANOX); (iii) a strong niche in tire phenolic resins; and (iv) niche specialty molecules (4,4'-biphenol). Since 2018, the investment case has been dominated by the leverage taken on in the SK Capital buyout. The 2024 and 2025 restructurings imply that operating cash flow could not service that debt during the 2023–2025 chemicals downturn.

Strategy

Stated strategy themes (company website, 2026; paraphrased):

Vision: become the global performance additives powerhouse (set in 2019).

Strategic pillars: anticipate customer problems and solve them with innovative chemistry; use the breadth of the global portfolio; run as one global organization with high business agility; execute "The Perfect Order" every time.

Mission: innovate and drive change to create value, with emphasis on safety, chemistry, sustainability and results.

Values: Results Matter; Reach Beyond Your Possible; Embrace the Grit; Lean In; Captivate Our Customers; Better Every Day; Do the Right Thing.

Strategic initiatives in the last 24 months (Oct 2024 – Oct 2026):

Medium-term financial targets and guidance: none disclosed.

Products & Services

Detailed specifications, pricing and launch years are generally NPD. SI Group sells on contract and quotation and does not publish list prices. Where a function is inferred from the chemistry class rather than stated by the company, this is noted.

Plastics

Brand / lineDescriptionKey capabilitiesTarget customerLaunch / latestPricing
ANOX™Hindered phenolic primary antioxidants (legacy Addivant/Chemtura brand)Long-term thermal stabilization of polyolefins, styrenics, engineering plasticsPolymer producers, compoundersLegacy; currentNPD
LOWINOX™Specialty phenolic antioxidants (legacy Addivant)Low-colour and low-volatility stabilization; also used in elastomersPolymer, elastomer, adhesive producersLegacy; currentNPD
WESTON™ (incl. WESTON 705)Phosphite secondary antioxidants. WESTON 705 is a next-generation, nonylphenol-free liquid phosphite for plastics and elastomersProcessing stabilization; removes nonylphenol concerns for regulated applications; capacity tripled within two years of launch (2014–2016)Polyolefin, PVC, elastomer producers; packaging2014–2016 launch; showcased at K 2025NPD
ETHANOX™Phenolic antioxidants (ex-Albemarle, acquired 2014)Stabilization for polymers, fuels and lubricantsPolymer and fuel/lube customersAcquired 2014NPD
POLYBOND™Chemically modified (grafted) polyolefin coupling agents and compatibilizers (legacy Addivant)Improve filler and glass-fibre adhesion and blend compatibilityCompounders, automotive plasticsLegacy; currentNPD
EVERCYCLE™Additive platform for recycled plastics and circularityRestabilizes and upgrades recycled polyolefins (e.g., recycled PP)Recyclers, packaging and consumer-goods convertersLaunched 2022NPD
UV Light StabilizersUV absorbers and stabilizers (product technology category)Weathering protectionOutdoor and automotive plasticsCurrentNPD
Non-dust blendsPre-blended, low-dust additive packagesHandling safety and dosing accuracyPolymer producersCurrentNPD
PFAS-free and "Arvin-free" technologiesNew solutions presented at K 2025 for automotive, packaging and consumer applicationsRegulatory-driven substitutionAutomotive and packaging OEMsPresented Oct 2025NPD

Rubber & Adhesives

Brand / lineDescriptionKey capabilitiesTarget customerLaunch / latestPricing
Tackifying resins (alkylphenol-formaldehyde Novolac)Provide building tack in green-tire assemblyLote, India capacity expanded ~75% (2021–2022)Tire makers (especially India/APAC)Expansion completed 2022NPD
Reinforcing resinsPhenolic resins that raise compound hardness and modulusTread, bead and apex compoundsTire and technical rubber goodsCurrentNPD
Bonding resinsRubber-to-cord adhesion systemsSteel and textile cord adhesionTire makersCurrentNPD
Curing resins / curing acceleratorsPhenolic resin cure systems (e.g., for butyl bladders)Heat-resistant crosslinkingTire bladder and technical rubber makersCurrentNPD
NAUGARD™ antidegradantsAminic and phenolic antioxidants and antiozonants (legacy Chemtura/Addivant)Protection against heat, oxygen and ozoneTire and rubber makers; also lubricantsLegacy; currentNPD
NAUGARD BIO-XLRubber additive that does not release the harmful nitrosamines listed in TRGS 552Supports nitrosamine compliance in rubberTechnical rubber, EU customersShowcased K 2025NPD
Adhesive tackifiersPhenolic tackifiers for adhesivesHot-melt and solvent-borne adhesive tackAdhesive formulatorsCurrentNPD

Fuel, Lubricants & Coatings

Brand / lineDescriptionKey capabilitiesTarget customerPricing
Lubricant and grease antioxidants (aminic, NAUGARD family; phenolic, ETHANOX/ANOX)Oxidation inhibitors for engine oils, industrial lubricants and greasesExtend drain intervals and thermal stabilityLubricant additive and oil companiesNPD
Alkylated phenols for lubricant additivesIntermediates for detergents and antioxidants used in automotive engine oilsBackward-integrated alkylphenol supplyLube additive majorsNPD
Fuel antioxidantsHindered-phenol stabilizers for fuels and biofuelsGum and peroxide preventionRefiners, biofuel producersNPD
Can-coatings resins / intermediatesPhenolic resins for internal can coatings (website application category)Food-contact coatingsCoatings formulatorsNPD

Oilfield

Brand / lineDescriptionTarget customerPricing
Asphaltene inhibitors (product technology)Resins that prevent asphaltene deposition in production systemsOilfield chemical formulatorsNPD
Demulsifier / production-chemistry resin intermediatesAlkylphenol-formaldehyde resin intermediates for demulsifiersOilfield service companiesNPD
ETHAFLOW™, CERIFLOW™Branded oilfield and flow-related product lines in the company catalogue.Oilfield formulatorsNPD

Core Solutions (Chemical Intermediates)

ProductDescriptionSite / notePricing
Alkylphenol intermediates (e.g., tert-butyl phenols)Building blocks for antioxidants, resins, UV absorbers and lube additives. SI Group claims market leadershipSupplied from Europe and the Americas after the Singapore closureNPD
Specialty alkylphenols and alkyl cresolsIntermediates for high-performance antioxidantsPratteln, Switzerland (since 1994 acquisition)NPD
4,4'-BiphenolMonomer for liquid crystal polymers (LCP), polyphenylsulfone (PPSU) and other high-performance materialsNewport, Tennessee; and, from 2026, the Shengnova JV in Sichuan, ChinaNPD
Phenolic resins (product technology)Industrial phenolic resins retained in the U.S. and China after the 2021 saleU.S. and ChinaNPD

Pharmaceuticals (legacy / contracting)

ProductStatusSource
Ibuprofen API (bulk, with DMF/CEP/JDMF per directory)Acquired from Albemarle in 2014, which made SI Group a top-3 global supplier at the time. Production at Orangeburg, SC ended in 2024 (74 jobs; WARN notice 26 Jun 2024). The company cited being unable to supply ibuprofen competitivelyAlbemarle/SI PRs 2014; WARN; Times and Democrat Jul 2024
Propofol APIAcquired 2014. Current status NPD. Directory listings persistPharmaCompass
Ibuprofen sodiumListed in directory; current status NPDPharmaCompass

Services

ServiceDescription
Application development and technical serviceDelivered through six innovation centres: Houston TX; Rotterdam Junction NY; Morgantown WV; Four Ashes UK; Lote India; Shanghai China. The Four Ashes centre focuses on plastics and rubber application development and analytical characterization
Supply-security modelMulti-site supply, co-production (Dingjide) and JV supply (Shengnova). The company also commits to "The Perfect Order" service standard

Financial Narrative

Disclosure status. SI Group files no public financial statements. Its debt is privately placed and syndicated (term loans and formerly unsecured notes), and the restructuring documents are not public. Every line in the requested income statement, balance sheet, cash flow and ratio tables is therefore not publicly disclosed for FY2021–FY2025. Blank cells in the chartable tables below mean NPD and are not zeros. The only quantitative disclosures available are company-stated scale indicators and capital-structure facts.

Company-stated scale indicators (chartable)

Sources and notes:

  • FY2018 sales are the sum of pre-merger SI Group (~USD 1B) and Addivant (~USD 500M), per ERJ, Oct 2018.

  • FY2019 and FY2020 figures come from company boilerplates of Aug 2019 and Dec 2020 ("approximately $2 billion in annual sales"; "more than 3,000 employees"; "more than 30 facilities"). The 2019 figure cites "more than 30 facilities on five continents".

  • FY2021 figures are from the Nov 2021 PR (21 facilities, four continents, 90 countries, ~2,300 employees).

  • FY2022 facility count is from the Aug 2022 Baytown Sun (20 facilities).

  • FY2024 figures are from the Feb 2024 PR (20 facilities, three continents, 80 countries, ~2,000 employees).

  • FY2025 figures are from the Dec 2025 PR (18 facilities, ~1,600 employees, 80 countries).

  • FY2026 figures are from the Mar–Jul 2026 PRs (~1,500 employees, 18 facilities, 80+ countries).

  • "3000" is a floor ("more than 3,000"). Revenue after FY2020 is not disclosed.

Income statement (chartable; all NPD)

EPS and DPS do not apply to a privately held company with no public share count. Revenue CAGR FY2021–FY2025 is NPD.

Commentary on trends, inflections and drivers

Scale contraction (2019 → 2026). The disclosed indicators show a business that has shrunk deliberately and under pressure. Headcount fell about 50% (from more than 3,000 to about 1,500). Plant count fell about 40% (from 30+ to 18). The country reach of the customer base dropped from about 90 to about 80. Part of this was strategic pruning:

  • the industrial resins sale to ASK Chemicals in 2021;

  • the Navi Mumbai site sale in 2022;

  • the move to an asset-light approach in China through the Dingjide co-production deal in 2024.

Part was retreat from uncompetitive positions:

  • ibuprofen at Orangeburg (2024);

  • Singapore alkylphenols, where the company cited regional supply-demand shifts and high Singapore costs (2024–2025).

The ~USD 2B revenue claimed in 2019–2020 almost certainly included the businesses since divested. Current revenue is not disclosed and should not be assumed to be USD 2B.

Leverage as the defining financial variable. SK Capital's 2018 buyout used committed debt financing (SK Capital PR, Oct 2018). By 2024 the company needed a liability-management exercise: an exchange extending maturities to 2028 plus USD 150M of sponsor equity. Fifteen months later a second, deeper recapitalization removed about USD 1.7B of net debt, more than 80% of the total. That sequence implies three things. Pre-2025 net debt was roughly USD 2B. EBITDA during the 2023–2025 chemicals destocking cycle was too low to service it. Most of the economic value transferred to lenders, and SK Capital's equity was very likely impaired; the release mentions advisers to "current equity holders" and a new ownership group, so this is a reasonable inference.

Pricing as a recurring lever. The company used broad price increases repeatedly:

  • rubber and adhesive additives up 15–20% (Dec 2020) and up to 25% (Nov 2021);

  • plastics additives up to 20% (Apr 2021);

  • a freight surcharge-type increase (Feb 2024);

  • a portfolio-wide increase tied to Middle East geopolitical, energy and logistics disruption (Mar 2026).

Post-recapitalization inflection (2026). After the restructuring the balance sheet is much lighter, which frees management to invest. The 2026 releases are growth-oriented: a JV, a centennial reinvestment pledge at Pratteln, and a strategic-marketing elevation. Profitability data needed to confirm an operating turnaround remain NPD.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Strategic Market Details

Strategic market (company-defined)ContentsRepresentative productsSegment revenue (3 yrs)Segment profit / margin% of total

Plastics

Polymer stabilization, compounding, circularity

ANOX, LOWINOX, WESTON, ULTRANOX-type phosphites, POLYBOND coupling agents, EVERCYCLE, UV light stabilizers, non-dust blends

NPD

NPD

NPD

Rubber & Adhesives

Tire and technical rubber resins, antidegradants, adhesive tackifiers

Tackifying, reinforcing, bonding and curing phenolic resins; NAUGARD antidegradants; NAUGARD BIO-XL

NPD

NPD

NPD

Fuel, Lubricants & Coatings

Antioxidants, intermediates and specialty additives

ETHANOX, NAUGARD (aminic) lubricant antioxidants, alkylphenol intermediates, can-coating resins

NPD

NPD

NPD

Oilfield

Production-chemistry resins and intermediates

Asphaltene inhibitors, demulsifier resin intermediates, ETHAFLOW / CERIFLOW-branded lines (function per company catalogue)

NPD

NPD

NPD

Core Solutions

Chemical intermediates for industrial uses

Alkylphenols (e.g., tert-butyl phenols), alkyl cresols, 4,4'-biphenol, phenolic resins

NPD

NPD

NPD

Key Financials and Operating Metrics (count)

MetricFY2018FY2019FY2020FY2021FY2022FY2024FY2025FY2026

Annual sales, company-stated approx. (USD Mn)

1,5002,0002,000—————

Employees, approx. (count)

3,0003,0003,0002,300—2,0001,6001,500

Manufacturing facilities (count)

3030302120201818

Countries with customers (count)

—909090—808080

Financial Analysis

ItemDetailSource

Sep–Oct 2024 exchange

~100% of first-lien lenders and 89% of unsecured noteholders participated at initial settlement (30 Sep 2024)

Company PR 2 Oct 2024; Latham 8 Oct 2024

Maturities after 2024 exchange

Extended to 2028

Company PR Oct 2024

Revolver (2024)

New USD 218M revolving credit facility with "full access"

Company PR Oct 2024

Sponsor support (2024)

USD 150M new money from SK Capital and affiliates to bolster liquidity and repay debt

Company PR Oct 2024

Interest (2024)

Overall reduction in annual cash interest expense; amount NPD

Company PR Oct 2024

Dec 2025 recapitalization

Net indebtedness reduced by ~USD 1.7B (described as over 80%); revolver amended

Company PR 23/24 Dec 2025

New capital (2025)

USD 150M junior capital from the new institutional ownership group

Company PR Dec 2025

Implied pre-recap net debt

If USD 1.7B equals "over 80%", pre-recap net debt was below ~USD 2.1B and post-recap net debt below ~USD 0.4B. This is analyst derivation, not disclosed

Derived

Lender group advisers (2025)

Akin Gump (legal) and Lazard (banker) to an ad hoc group of second-out term-loan lenders. The term "second-out" implies a first-out/second-out structure created in 2024

Company PR Dec 2025

Company advisers (2025)

Latham & Watkins (legal), PJT Partners (banker), AlixPartners (financial). Baker Botts advised existing equity holders

Company PR Dec 2025

Holding structure

New holding structure built through Luxembourg

Loyens & Loeff 2025/26

Key Financials

MetricFY2024FY2025

Sponsor / new-owner capital injected (USD Mn)

150150

Region Overview

RegionDirection (inferred)EvidenceSource

North America

Core and stable; HQ and most plants

7 U.S. manufacturing sites, HQ and two innovation centres in Texas; ibuprofen exit at Orangeburg (2024)

siigroup.com/locations; WARN 2024

Europe

Investment and distribution expansion

European Innovation Centre opened Oct 2025; Azelis added as EMEA plastics-additive distributor alongside Brenntag from 1 Jan 2026; Pratteln centennial with reinvestment commitment (May 2026)

Company PRs 2025–26

China / East Asia

Asset-light restructuring, then selective re-entry via JV

Jinshan closure (2024) with Dingjide co-production; Shengnova biphenol JV (Jun 2026) targeting electronics, automotive and medical demand

Company PRs 2024, 2026

Southeast Asia

Declining

Singapore alkylphenol plant closure (H2 2025)

Company PR Sep 2024

India

Growth hub for tire resins

Lote tackifier capacity +75% (2021–22); Lote innovation centre; Navi Mumbai plant sold (2022) but commercial staff kept

Company PRs 2021–22, 2025

Latin America

Reduced

Rio Claro industrial-resin assets sold to ASK (2021). Related businesses retained; the Rio Claro address now maps to ASK Crios premises, suggesting shared-site arrangements (inference)

Company PR Nov 2021; siigroup.com/locations

Africa

Exited (manufacturing)

Johannesburg site sold to ASK (2021)

Company PR Nov 2021

Middle East

JV presence

Gulf Stabilizers Industries (Saudi Arabia) JV since 2000

siigroup.com/about

Capital Markets

ItemStatus

Share price performance (1/3/5-year)

Not applicable (no listed equity)

Valuation multiples (P/E, EV/EBITDA, EV/Sales, P/B)

Not applicable / NPD

Peer multiples

Not computed (no SI Group base to compare)

Analyst consensus

None (no equity coverage)

Dividend history / policy

NPD. Private; no public dividend policy

Credit ratings (Moody's / S&P / Fitch)

Under S&P criteria, distressed exchanges such as the 2024 transaction are typically treated as selective default, absent adequate compensation. That is a general criteria point, not a confirmed SI Group action

Debt maturity profile

After Sep 2024: maturities extended to 2028, USD 218M revolver. After Dec 2025: revolver amended; residual debt quantum and maturity ladder NPD

Valuation reference

CB Insights estimates the 2018 SK Capital acquisition at USD 1.5–2.5B (estimate)

Analyst Conclusions

Management guidance: none published. The qualitative direction from 2026 communications is growth investment, operational improvement and customer focus, enabled by the December 2025 recapitalization.

Consensus growth expectations: none exist (no coverage).

Bull case

  1. Balance-sheet reset: cutting more than 80% of net debt removes the interest drag that forced two restructurings. Even modest EBITDA can now produce free cash flow for reinvestment (PR Dec 2025).

  2. Higher-growth niches: biphenol for LCP/PPSU (Shengnova JV), circular-plastics additives (EVERCYCLE) and regulatory-substitution products give SI Group exposure beyond commodity antioxidants (PRs 2025–26).

  3. Lean footprint: after the Jinshan, Singapore and ibuprofen exits, the remaining 18-site network is concentrated in competitive positions (alkylphenol integration in the U.S. and Europe, the India tire-resin hub), which should lift margins as volumes recover.

Bear case

  1. Scale erosion: headcount halved and plant count down about 40% since 2019–20. Revenue is undisclosed and may be well below the old ~USD 2B. The company may lack the scale to compete with BASF, Songwon and Chinese producers.

  2. Re-default risk: industry data show high re-default rates after distressed exchanges. The amended revolver and any remaining debt still depend on a cyclical chemicals recovery that had not been evident through 2025.

  3. Ownership uncertainty: an unnamed, credit-oriented owner group (AIP Credit Opportunities is inferred) may favour a near-term exit or carve-ups over long-term building. The CCO departure and new ELT appointments add execution risk.

Key catalysts and monitorables (next 12 months)

  • Any disclosure of owner identities, board chair appointment, or a sale or carve-out process.

  • Start-up and offtake of the Shengnova biphenol JV; continued Newport production.

  • Azelis channel performance in EMEA plastics additives during 2026.

  • Further price actions, or reversals, as Middle East logistics and energy conditions evolve.

  • Credit-agency actions on the post-recapitalization structure.

  • New plant closures or reinvestments (Pratteln commitment; Orangeburg site use after ibuprofen).

  • 2026 EcoVadis follow-through and quantified ESG targets.

Analyst verdict

SI Group is no longer the ~USD 2B, 30-plant, 3,000-person conglomerate of specialty chemistries that SK Capital assembled in 2018. Since 2021 it has sold its industrial-resins business, its Navi Mumbai plant and its upstate New York campus. It has closed or exited Jinshan, Singapore and Orangeburg ibuprofen. It has gone through two restructurings in fifteen months, ending in December 2025 with lenders and a new institutional ownership group taking control and about USD 1.7B of net debt written away. The company left behind is smaller (about 1,500 employees and 18 plants) and much less leveraged, and its strategy is more focused. It is built around antioxidants and stabilizers backed by in-house alkylphenols, phenolic tire resins centred on India, and selected high-performance intermediates such as biphenol.

The 2026 newsflow is notably constructive for a company only months out of a restructuring. It includes a China JV, an EMEA distribution expansion, an EcoVadis upgrade, a centennial reinvestment pledge and a commercial-leadership promotion. This reads as a management team that now has the financial room to play offence. The core problem has not changed, however. In its largest product categories SI Group remains a mid-tier player against far larger and lower-cost rivals. Without published financials, investors and counterparties cannot test whether margins have recovered from the 2023–2025 trough.

Our assessment is cautiously constructive on survival and stability, neutral on value creation. Restructuring risk has fallen sharply in the near term. The medium-term thesis now depends on proving that the slimmed portfolio can grow profitably, first in biphenol, circularity additives and India tire resins. Counterparties should seek owner-level transparency and current credit ratings before extending material exposure. Potential acquirers should treat SI Group as a likely candidate for an owner-led sale or asset-by-asset monetization within the typical credit-fund holding period.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenurePrior rolesEducationAgeCompensation

David Bradley

President & CEO; director

Since 18 Mar 2019

President & CEO, Nexeo Solutions; ~7 years at Kraton Performance Polymers incl. COO; career began at GE Plastics. Outside boards: Ecovyst, South Texas Truck Centers

B.S. Chemical Engineering, University of Louisville

NPD

NPD (no proxy)

Rustom Jilla

SVP & CFO

Since 5 Jan 2022

CFO of IFF (through the DuPont N&B merger); CFO roles at MSC Industrial Direct, Dematic Group, Ansell

NPD

NPD

NPD

Robert Kaiser

SVP, Strategic Marketing (joined ELT)

Promoted 13 Jul 2026; with SI Group since 2014

VP Strategic Marketing & MD EMEA; VP Rubber & Adhesives Solutions; earlier AkzoNobel and Arizona Chemical (now Kraton)

MBA, Ruhr University Bochum

NPD

NPD

Brooke Manrique

SVP, Human Resources & Communications

In role by 2022

NPD

NPD

NPD

NPD

Paul Tilley

SVP, Business Development

NPD

NPD

NPD

NPD

NPD

Mike Farnell

SVP, General Counsel & Chief Sustainability Officer

In role by Mar 2026 (not shown on the ELT web page)

NPD

NPD

NPD

NPD

Board of Directors

DirectorBackgroundOther boardsIndependence (assessed)

Shawn Abrams

Former President, Catalyst Technologies, W.R. Grace

Clean Chemistry; PQ Corporation; Savillex

Non-executive

Luis Fernandez-Moreno

Former Interim President & CEO, Ingevity

HASA Pool; Huber Engineered Materials; Ingevity; Select Water Solutions

Non-executive

Daryl Roberts

Former SVP, Chief Operations & Engineering Officer, DuPont

AdvanSix; American Electric Power

Non-executive

Jan Trnka-Amrhein

Partner, Credit Opportunities, American Industrial Partners

Apex Tool Group; Envivia Biomass

Owner representative (likely)

David Bradley

President & CEO, SI Group

Ecovyst; South Texas Truck Centers

Executive

Board & Management Changes

DateChangeContextSource

May 2013

Frank Bozich succeeds Stephen Large as CEO

Growth/M&A era (Albemarle deal)

PR 6 May 2013

Oct 2018

Post-merger leadership: Frank Bozich (CEO) and John Steitz (CEO, Additives segment)

SK Capital merger with Addivant

SK Capital PR 2018

Late 2018 – Mar 2019

David Mezzanotte (SK Capital) interim CEO

Bozich departure; search

PR Mar 2019

18 Mar 2019

David Bradley CEO

Transformation programme

PR Mar 2019

5 Jan 2022

Rustom Jilla replaces Patrick Weinberg as CFO

Pre-refinancing finance upgrade

PR Jan 2022

2024

Joey Gullion serving as SVP & Chief Commercial Officer

Led China and Singapore footprint moves

PRs Feb & Sep 2024

By 2026

Gullion no longer listed on the ELT; departure date NPD

Commercial leadership re-cut

siigroup.com/about

Dec 2025

Board reconstituted under new ownership (inferred)

Recapitalization

siigroup.com/about

13 Jul 2026

Robert Kaiser promoted to SVP Strategic Marketing, joins ELT

Commercial growth strategy

PR 13 Jul 2026

Major Shareholders

HolderStakeNote

New institutional ownership group (members not disclosed)

Controlling (inferred)

USD 150M junior capital, Dec 2025

American Industrial Partners (Credit Opportunities)

NPD; unconfirmed

Inferred from board seat

SK Capital Partners and affiliates

Residual stake, if any, NPD

Sponsor from 2018 to Dec 2025

Insider / management ownership

NPD

—

Competitive Landscape

Peer Comparison

SI Group marketNamed competitors (minimum 8–10 overall)

Plastics antioxidants and stabilizers

BASF (Irganox/Irgafos/Tinuvin); Songwon Industrial (Korea); Adeka (Japan); Rianlon (China); Clariant (additives); Dover Chemical (phosphites; ICC Industries); Sumitomo Chemical

Rubber chemicals and tire resins

Lanxess (rubber additives); Flexsys (ex-Eastman tire additives); Sino Legend (China, phenolic tackifier resins); Sumitomo Bakelite; Kumho Petrochemical; Struktol

Lubricant and fuel antioxidants

BASF; Lanxess; Vanderbilt Chemicals; Lubrizol and Afton (captive and merchant additive majors)

Alkylphenols and intermediates

Dover Chemical; Chinese alkylphenol producers; integrated phenol producers (identities and shares NPD)

Oilfield production chemicals (resin intermediates)

Formulators such as SLB/ChampionX and Baker Hughes, plus merchant resin suppliers (overlap partial)

Biphenol

Shengxiao (now JV partner); other Chinese and Japanese producers (NPD)

Peer Comparison FY2024

CompanyOwnershipLatest revenue (FY, currency)GrowthMarginsR&D intensityNote

SI Group

Private

NPD (~USD 2B claimed for 2019–2020, before divestitures)

NPD

NPD

NPD

18 plants; ~1,500 staff (2026)

BASF SE

Listed (XETRA: BAS)

~EUR 65.3B, group (FY2024, annual report).

See filings

See filings

See filings

Global leader in polymer additives

LANXESS AG

Listed (XETRA: LXS)

~EUR 6.4B, group (FY2024, annual report)

See filings

See filings

See filings

Rubber chemicals and lubricant additives overlap

Songwon Industrial

Listed (KRX)

————

No.

Recent Developments

SI Group is a private company with a low disclosure cadence. To give context, the register is extended back to February 2024.

Not identified in public sources during the window: * guidance revisions, contract wins, litigation or regulatory actions.

Company Snapshot

1,500

Employees

1906

Founded

NY in, US

Headquarters

SWOT Analysis

Strengths

  • Deleveraged balance sheet: net indebtedness reduced by about USD 1.7B (>80%) in December 2025, plus USD 150M of fresh junior capital (PR Dec 2025).
  • Integrated alkylphenol base: the company claims alkylphenol market leadership with supply points in Europe and the Americas (PR Sep 2024). Pratteln has made specialty alkylphenols and alkyl cresols for decades (PR Jun 2026).
  • Brand heritage: the NAUGARD, ANOX, LOWINOX, WESTON, POLYBOND and ETHANOX franchises are built from Addivant/Chemtura (2018) and Albemarle (2014) (website; PRs).
  • Innovation network: six innovation centres across three continents, including the new Four Ashes EIC (PR Oct 2025).
  • Product pipeline matched to regulation: nonylphenol-free WESTON 705, nitrosamine-free NAUGARD BIO-XL, and PFAS-free solutions (PR Sep 2025).
  • ESG momentum: EcoVadis improved from Bronze (2025) to Silver (85th percentile, 2026), above the industry average in all four themes (PR Mar 2026).
  • India tire-resin hub: Lote tackifier capacity expanded about 75% (PR May 2021).

Weaknesses

  • Repeated financial distress: two capital-structure transactions within 15 months (Sep 2024; Dec 2025) (PRs).
  • Shrinking scale: employees down from 3,000+ (2019–20) to about 1,500 (2026); plants down from 30+ to 18 (boilerplates).
  • Opacity: no public financials, which limits customer and counterparty assessment and makes trade-credit terms harder to obtain.
  • Uncompetitive legacy assets: ibuprofen exit (2024, 74 jobs); Singapore closure for high cost (PR Sep 2024).
  • Leadership churn: CCO Joey Gullion (prominent in 2024) is no longer on the ELT; four CFO and CEO transitions since 2018 (PRs; website).
  • Unclear ownership: the new owners are not named, which makes strategic direction and holding period uncertain.

Opportunities

  • Biphenol for LCP/PPSU: the Shengnova JV gives in-region supply into electronics, automotive and medical demand (PR Jun 2026).
  • Circular-plastics additives: EVERCYCLE and recycled-PP solutions serve recycled-content mandates (website; PR Sep 2025).
  • EMEA channel: Azelis broadens plastics-additive reach from 2026 (PR Oct 2025).
  • Post-recapitalization reinvestment: management says the new capital will fund operational initiatives and growth (PR Dec 2025); Pratteln reinvestment has been pledged (PR Jun 2026).
  • Regulatory substitution: PFAS, nonylphenol and nitrosamine restrictions favour suppliers with ready alternatives (PR Sep 2025).
  • Pricing in a disrupted supply environment: the March 2026 price action shows an attempt to capture value during logistics and energy shocks (PR Mar 2026).

Threats

  • Chinese competition: the stated reason for restructuring the Jinshan and Singapore positions (PRs 2024).
  • Geopolitical, energy and logistics shocks: price increases in Feb 2024 (Panama and Suez) and Mar 2026 (Middle East) (PRs).
  • Automotive and tire demand cyclicality: affects the Rubber & Adhesives and Plastics markets.
  • EV transition: structural erosion of engine-oil antioxidant volumes over the long term (assessment).
  • Regulatory pressure on alkylphenols and their derivatives: the EU REACH scrutiny of phenolic substances is an industry-wide risk (the website hosts a REACH section).
  • Re-default risk: S&P research shows that issuers which complete distressed exchanges often default again (S&P Global Ratings research, 2023–24).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
21–22 Feb 2024Dingjide co-production partnership; Jinshan plant to close PRChina becomes asset-light
27 Feb 2024Global price increase to offset freight costs (Panama and Suez disruption) PRCost pass-through
26 Jun 2024WARN notice: 74 layoffs at Orangeburg, effective 1 Sep 2024 WARN; Times and DemocratExit from ibuprofen production
31 Jul 2024 (target)Jinshan manufacturing cessation ERJFootprint cut
18 Sep 2024Private debt exchange closed PRFirst restructuring
25 Sep 2024Singapore plant closure announced for H2 2025 PRAPAC footprint retreat
1–2 Oct 2024Exchange results: ~100% of 1L, 89% of unsecured; USD 150M sponsor money PRLiquidity runway to 2028
2025 (date NPD)EcoVadis Bronze (top 35%) PR Dec 2025 boilerplateESG step-down from 2021 Gold
31 Mar 2025APAC positioning
H2 2025Singapore alkylphenol operations cease (as planned; exact date NPD) PR Sep 2024; Dec 2025 boilerplatePlant count falls to 18
15 Sep 2025K 2025 showcase announced (Düsseldorf, 8–15 Oct 2025) PRProduct-pipeline visibility
2 Oct 2025Azelis EMEA distribution partnership PRChannel expansion
28 Oct 2025European Innovation Centre opens (Four Ashes, UK) PRR&D investment
23–24 Dec 2025Comprehensive recapitalization closes; ~USD 1.7B net-debt cut; new owners; USD 150M junior capital PR; Loyens & LoeffChange of control; deleveraging
7 Jan 2026Latham & Watkins publishes deal credential confirming termsCorroboration
1 Jan 2026Azelis partnership takes effect PR Oct 2025Channel
17 Mar 2026Portfolio-wide price increase (Middle East geopolitical disruption to energy and logistics) PRMargin defence
25 Mar 2026EcoVadis Silver (85th percentile); 2025 ESG Report referenced PRESG recovery
28 May 2026Pratteln centennial event PR 22 Jun 2026Site commitment
22 Jun 2026Centennial release published PR—
25 Jun 2026Shengnova biphenol JV with Shengxiao Group PRFirst growth JV after the recapitalization
13 Jul 2026Robert Kaiser promoted to SVP Strategic Marketing and joins ELT PRCommercial focus

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Income Statement

2 charts
Key Financials (FY2018–FY2020): Annual sales, company-stated approx. rose from USD 1,500 Mn in FY2018 to USD 2,000 Mn in FY2020.
SI Group, Inc. — Key Financials (FY2018–FY2020)
Series (USD Mn)FY2018FY2019FY2020
Annual sales, company-stated approx.1,5002,0002,000

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. SI Group, About / Leadership / Board / Timeline
  2. SI Group, Locations
  3. SI Group, News index
  4. SI Group PR, Kaiser promotion (13 Jul 2026)
  5. SI Group PR, Shengnova JV (25 Jun 2026)
  6. SI Group PR, Pratteln centennial (22 Jun 2026)
  7. SI Group PR, EcoVadis Silver (25 Mar 2026)
  8. SI Group PR, Price adjustments (17 Mar 2026)
  9. SI Group PR, Recapitalization closing (23 Dec 2025)
  10. AAP / PR Newswire syndication of the recapitalization release (24 Dec 2025)
  11. Loyens & Loeff, recapitalization credential
  12. Latham & Watkins, recapitalization (7 Jan 2026)
  13. SI Group PR, European Innovation Centre (28 Oct 2025)
  14. SI Group PR, Azelis partnership (2 Oct 2025)
  15. SI Group PR, K 2025 (15 Sep 2025)
  16. SI Group PR, Exchange offer results (Oct 2024)
  17. Latham & Watkins, 2024 exchange (8 Oct 2024)
  18. SI Group PR, Singapore closure (25 Sep 2024)
  19. SI Group PR, Dingjide partnership (Feb 2024)
  20. European Rubber Journal, China reorganization (26 Feb 2024)
  21. SI Group PR, Freight price increase (27 Feb 2024)
  22. Times and Democrat, Orangeburg ibuprofen exit (1 Jul 2024)
  23. LayoffTracker, WARN data
  24. SI Group PR, Niskayuna sale / HQ move (1 Jul 2022)
  25. PR Newswire India, Navi Mumbai sale (28 Apr 2022)
  26. Kyodo/PRN, CFO appointment (5 Jan 2022)
  27. SI Group PR, ASK Chemicals sale completion (1 Nov 2021)
  28. SI Group PR, Lote tackifier expansion (18 May 2021)
  29. SI Group PR, 2019 HQ move announcement
  30. SK Capital PR, SI Group acquisition completed (15 Oct 2018)
  31. European Rubber Journal, merger scale data (Oct 2018)
  32. SK Capital PR, CEO Bradley appointment (Mar 2019)
  33. Albemarle PR, sale to SI Group (2 Sep 2014)
  34. CB Insights profile
  35. PitchBook profile
  36. S&P Global Ratings, selective-default FAQ (Oct 2024)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.